郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

心血管疾病Cardiac action of the first G protein biased small molecule apelin agonist.

期刊：Biochemical pharmacology发表年份：2016作者：Cai Read; Christopher M Fitzpatrick; Peiran Yang; Rhoda E Kuc; Janet J Maguire; Robert C Glen; Richard E Foster; Anthony P Davenport
阅读更多 →

心血管疾病TRPC3 positively regulates reactive oxygen species driving maladaptive cardiac remodeling.

期刊：Scientific reports发表年份：2016作者：Naoyuki Kitajima; Takuro Numaga-Tomita; Masahiko Watanabe; Takuya Kuroda; Akiyuki Nishimura; Kei Miyano; Satoshi Yasuda; Koichiro Kuwahara; Yoji Sato; Tomomi Ide; Lutz Birnbaumer; Hideki Sumimoto; Yasuo Mori; Motohiro Nishida
阅读更多 →

心血管疾病Inhibitors of membranous adenylyl cyclases with affinity for adenosine receptors.

期刊：Naunyn-Schmiedeberg's archives of pharmacology发表年份：2016作者：Karl-Norbert Klotz; Sonja Kachler
阅读更多 →

心血管疾病Vascular endothelial growth factor A (VEGF-A) decreases expression and secretion of pleiotrophin in a VEGF receptor-independent manner.

期刊：Vascular pharmacology发表年份：2016作者：Evangelia Poimenidi; Christina Theodoropoulou; Marina Koutsioumpa; Lamprini Skondra; Eirini Droggiti; Marloes van den Broek; Pieter Koolwijk; Evangelia Papadimitriou
阅读更多 →